Swiss Medical Devices for Autologous Regenerative Medicine: From Innovation to Clinical Validation

被引:7
|
作者
Gomri, Farid [1 ]
Vischer, Solange [1 ]
Turzi, Antoine [1 ]
Berndt, Sarah [1 ,2 ]
机构
[1] Regen Lab SA, CH-1052 Le Mt Sur Lausanne, Switzerland
[2] Geneva Univ Hosp, Dept Plast Reconstruct & Aesthet Surg, Fac Med, CH-1205 Geneva, Switzerland
关键词
platelet-rich plasma; PRP; tissue regeneration; cell therapy; regenerative medicine; autologous biologics; ortho-biologics; hyaluronic acid; HA; good manufacturing practices; GMP; medical devices; PLATELET-RICH PLASMA; HYALURONIC-ACID; KNEE OSTEOARTHRITIS; GROWTH-FACTORS; CELLS; CLASSIFICATION; MACROPHAGES; LEUKOCYTE; OUTCOMES; RELEASE;
D O I
10.3390/pharmaceutics14081617
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Regenerative medicine, based on the use of autologous tissues and embryonic, stem or differentiated cells, is gaining growing interest. However, their preparation, in a manner compliant with good practices and health regulations, is a technical challenge. The aim of this manuscript is to present the design of reliable CE marked medical devices for the preparation of standardized platelet-rich plasma (PRP) and other autologous biologics intended for therapeutic uses. There are numerous PRP isolation processes. Depending on the methodology used, PRP composition varies greatly in terms of platelet concentration, platelet quality, and level of contamination with red and white blood cells. This variability in PRP composition might affect the clinical outcomes. The devices presented here are based on a specific technology, patented all over the world, that allows the precise separation of blood components as a function of their density using thixotropic separator gels in closed systems. This allows the preparation, in an automated manner, of leukocyte poor PRP with a standardized composition. Production of different forms of PRP is a clinical asset to suit various therapeutic needs. Therefore, we are offering solutions to prepare PRP either in liquid or gel form, and PRP combined with hyaluronic acid. These biologics have been successfully used in many different therapeutic domains, resulting in more than 150 published clinical studies. We also developed the CuteCell technology platform for cell culture expansion for further autologous cell therapies. This technology enables the safe and rapid in vitro expansion of cells intended for therapeutic use in good manufacturing practices (GMP) and autologous conditions, using blood-derived products as culture media supplementation. We summarize in this article our 20 years' experience of research and development for the design of PRP devices and, more recently, for PRP combined with hyaluronic acid.
引用
收藏
页数:24
相关论文
共 50 条
  • [1] INNOVATION IN REGENERATIVE MEDICINE: PERSPECTIVES FROM A LARGE MEDICAL DEVICE COMPANY
    Reiterer, Markus
    [J]. TISSUE ENGINEERING PART A, 2022, 28 : S651 - S651
  • [2] Regenerative Medicine at the Forefront of Innovation: Update From Japan
    Milne, Christopher-Paul
    Kaitin, Kenneth I.
    [J]. CLINICAL THERAPEUTICS, 2018, 40 (11) : 1798 - 1800
  • [3] Progress in Regenerative Medicine: Exploring Autologous Platelet Concentrates and Their Clinical Applications
    Giannotti, Laura
    Stanca, Benedetta Di Chiara
    Spedicato, Francesco
    Nitti, Paola
    Damiano, Fabrizio
    Demitri, Christian
    Calabriso, Nadia
    Carluccio, Maria Annunziata
    Palermo, Andrea
    Siculella, Luisa
    Stanca, Eleonora
    [J]. GENES, 2023, 14 (09)
  • [4] Collagen-Based Medical Devices for Regenerative Medicine and Tissue Engineering
    Abedi, Mehdi
    Shafiee, Mina
    Afshari, Farideh
    Mohammadi, Hamidreza
    Ghasemi, Younes
    [J]. APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY, 2024, 196 (08) : 5563 - 5603
  • [5] Does inventor centrality foster regional innovation? The case of the Swiss medical devices sector
    Coffano, Monica
    Foray, Dominique
    Pezzoni, Michele
    [J]. REGIONAL STUDIES, 2017, 51 (08) : 1206 - 1218
  • [6] Autologous fat injection to face and neck: from soft tissue augmentation to regenerative medicine
    Mazzola, R. F.
    Cantarella, G.
    Torretta, S.
    Sbarbati, A.
    Lazzari, L.
    Pignataro, L.
    [J]. ACTA OTORHINOLARYNGOLOGICA ITALICA, 2011, 31 (02) : 59 - 69
  • [7] TRANSLATION OF VASCULAR REGENERATIVE MEDICINE, FROM PRECLINICAL TO CLINICAL OPTIMIZATION
    Takagi, Gen
    Miyamoto, Masaaki
    Tara, Shuhei
    Takagi, Ikuyo
    Kirinoki-Ichikawa, Sonoko
    Takano, Hitoshi
    Tabata, Yasuhiko
    Mizuno, Kyoichi
    [J]. WOUND REPAIR AND REGENERATION, 2012, 20 (01) : A3 - A3
  • [8] Regulatory requirements for regenerative medicine: From research to clinical application
    Kloth, S.
    [J]. CYTOTHERAPY, 2006, 8 : 20 - 20
  • [9] Decellularized xenografts in regenerative medicine: From processing to clinical application
    Capella-Monsonis, Hector
    Zeugolis, Dimitrios I.
    [J]. XENOTRANSPLANTATION, 2021, 28 (04)
  • [10] Regenerative medicine of the intervertebral disc From pathophysiology to clinical application
    Henry, Nina
    Colombier, Pauline
    Lescaudron, Laurent
    Hamel, Olivier
    Le Bideau, Jean
    Guicheux, Jerome
    Clouet, Johann
    [J]. M S-MEDECINE SCIENCES, 2014, 30 (12): : 1091 - 1100